Investigational Site Number : 8260015

London SW10 0LR

0 studies enrolling now · 1 studies all time

What they study most

COVID-19

Studies at this site

• Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older — Completed